Effects on quality of life, anti-cancer responses, breast conserving surgery and survival with neoadjuvant docetaxel: a randomised study of sequential weekly versus three-weekly docetaxel following neoadjuvant doxorubicin and cyclophosphamide in women with primary breast cancer

BACKGROUND: Weekly docetaxel has occasionally been used in the neoadjuvant to downstage breast cancer to reduce toxicity and possibly enhance quality of life. However, no studies have compared the standard three weekly regimen to the weekly regimen in terms of quality of life. The primary aim of our...

Descripción completa

Detalles Bibliográficos
Autores principales: Walker, Leslie G, Eremin, Jennifer M, Aloysius, Mark M, Vassanasiri, Wichai, Walker, Mary B, El-Sheemy, Mohamed, Cowley, Ged, Beer, Jeanette, Samphao, Srila, Wiseman, Janice, Jibril, Jibril A, Valerio, David, Clarke, David J, Kamal, Mujahid, Thorpe, Gerald W, Baria, Karin, Eremin, Oleg
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2011
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3117815/
https://www.ncbi.nlm.nih.gov/pubmed/21592370
http://dx.doi.org/10.1186/1471-2407-11-179

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3117815/
https://www.ncbi.nlm.nih.gov/pubmed/21592370
http://dx.doi.org/10.1186/1471-2407-11-179

Ejemplares similares